{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["27(2)"],"submitter":["Hua A"],"pubmed_abstract":["<h4>Background</h4>Cardiovascular magnetic resonance (CMR) is the principal non-invasive imaging modality used to diagnose idiopathic/viral myocarditis. The revised Lake Louise criteria (LLC) stipulate that a diagnosis can be made in the presence of one T1-based and one T2-based criterion. While the LLC have been extensively validated in viral myocarditis, their utility for the diagnosis of myocarditis due to an active autoimmune rheumatic disease is unknown. This study sought to assess the performance of the revised LLC in patients with clinically suspected myocarditis due to active systemic autoimmune disease.<h4>Methods</h4>Patients with clinically active autoimmune rheumatic disease, symptoms of myocarditis, and elevated troponin levels were recruited and compared with controls with au"],"journal":["Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance"],"pagination":["101916"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12445391"],"repository":["biostudies-literature"],"pubmed_title":["Diagnostic utility of the revised Lake Louise criteria in myocarditis associated with active autoimmune rheumatic disease."],"pmcid":["PMC12445391"],"pubmed_authors":["Ismail TF","Chiribiri A","Sanna G","Domenech-Ximenos B","Hua A","Lopez B","Marber M","Rajani R","Fernando M","D'Cruz D"],"additional_accession":[]},"is_claimable":false,"name":"Diagnostic utility of the revised Lake Louise criteria in myocarditis associated with active autoimmune rheumatic disease.","description":"<h4>Background</h4>Cardiovascular magnetic resonance (CMR) is the principal non-invasive imaging modality used to diagnose idiopathic/viral myocarditis. The revised Lake Louise criteria (LLC) stipulate that a diagnosis can be made in the presence of one T1-based and one T2-based criterion. While the LLC have been extensively validated in viral myocarditis, their utility for the diagnosis of myocarditis due to an active autoimmune rheumatic disease is unknown. This study sought to assess the performance of the revised LLC in patients with clinically suspected myocarditis due to active systemic autoimmune disease.<h4>Methods</h4>Patients with clinically active autoimmune rheumatic disease, symptoms of myocarditis, and elevated troponin levels were recruited and compared with controls with au","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jun","modification":"2026-06-03T15:22:26.868Z","creation":"2026-04-29T03:11:52.143Z"},"accession":"S-EPMC12445391","cross_references":{"pubmed":["40467038"],"doi":["10.1016/j.jocmr.2025.101916"]}}